News
-
Humana Taps Interwell Health for Kidney Care
In a new agreement, Interwell Health will provide care to Humana Medicare Advantage HMO and PPO members with chronic kidney disease in 13 states. It will also serve patients with end-stage kidney disease across the country.
-
Devices & Diagnostics, Health Tech
FDA Clears New Surgical Platform Combining Robotics & Magnetics
The FDA cleared Levita Magnetics’ new abdominal surgery platform, which combines the company’s proprietary magnetic surgical technology with robotic assistance. The system is designed to deliver all the same patient benefits as its original magnetic surgery system — such as reduced incisions, less pain, fewer scars and speedier recovery — while also giving surgeons better control of their instruments.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Innovations in Dementia Care: Exploring the Role of Medical Devices and Medications
Dementia patients require a balanced blend of supportive devices, effective medications such as cholinesterase inhibitors and holistic understanding to truly enjoy the best possible quality of life.
-
MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials
The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner.
-
Innovaccer Unveils AI Suite With Automation Tools For Doctors, C-Suite Execs, Care Managers & More
Innovaccer announced a new suite of healthcare products. It comprises four different solutions — one for answering healthcare executives’ questions about their business metrics, one for automating care planning and documentation, one for generating clinical visit summaries, and one for streamlining workflows at contact centers.
-
Teva, Glenmark To Pay $255M, Divest Cholesterol Drug to Settle DOJ Price Fixing Charges
Generic drugmakers Teva and Glenmark recently became the sixth and seventh drugmakers to resolve criminal charges as a result of the DOJ’s yearslong investigation into generic drug price fixing. The settlement agreement requires both companies to pay hefty fines as well as divest their drug lines for pravastatin, a widely used statin that lowers cholesterol.
-
Colon Cancer Screening: Health Empowerment for the Whole Family
While we’re catching a high-risk population through preventive screenings, we are also identifying an entirely separate high-risk population: children of the patients that were just screened and found to have high risk polyps such as greater than 1 cm or with certain advanced characteristics.
-
Nashville Entrepreneur Center Gears Up for Virtual Care Delivery Conference September 21
Telehealth Academy III, a conference exploring the virtual care delivery landscape, will be one of the highlights of an inaugural week of events organized in the healthcare provider hub of Nashville, referred to as Nashville Healthcare Sessions.
-
Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery
Genesis Therapeutics recently joined the growing list of AI-powered drug discovery startups receiving venture funding this year. The company closed a $200 million Series B financing round, taking its total funding to date to more than $280 million.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff
Healthcare M&A deals are expected to pick up over the next few months, and one expert is predicting that the biopharma sector in particular will see especially robust activity. M&A lawyer Matt Gardella said there are three sets of market circumstances that will lead to an influx of biopharma deals: a looming patent cliff, shrinking valuations and a weak IPO market.
-
MedCity Influencers, Artificial Intelligence
Prediction is Power: The Truth About What is AI, Really
Do some people simply think the A in AI stands for Automation? Most likely the confusion is due to a lack of understanding of what AI truly is, combined with a strong desire to use the term for marketing purposes.
-
Consumer / Employer, Health Tech
Spring Health Launches Mental Health Education Platform for Workplaces
Spring Health launched Sage, a platform that offers asynchronous video lessons to help employees manage their own mental health and support managers in creating a healthy work environment.
-
MedCity Influencers, Devices & Diagnostics
A More Predictive and Preventive Cardiothoracic Imaging Interpretation Model to Avoid Delayed Diagnoses
The current imaging interpretation model undoubtedly has reached its breaking point due to increasing volumes and fewer radiologists. The time is now to solve this systemic imaging interpretation issue.
-
Here’s Why Many Americans Are Unable to Afford Their Drugs
Pharmaceutical manufacturers say high U.S. prices support research and development and point out that Americans tend to get new treatments first. But recent research has shown that the price of a drug is related neither to the amount of research and development required to bring it to market nor its therapeutic value.
-
Report: Weight Loss Drugs Cost Significantly More for Americans than Peer Countries
A new KFF analysis compared list prices for Ozempic, Wegovy, Rybelsus and Mounjaro. It found that the U.S. has much higher list prices for these drugs than other peer countries while also having the highest rate of obesity.
-
Why OneOncology Is Adopting Verily’s Clinical Trial Management System
OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.
-
Devices & Diagnostics, Health Tech
Medtech Funding Expected to Pick Up In 2023 After Q1’s Low Point
Medtech funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023, according to a new Pitchbook report. It noted that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even come in below last year’s funding total of $13.5 billion.
-
Why 2 CEOs Are Clamoring For New Primary Care Payment Models
Fee-for-services payment models in the primary care ecosystem are doing a poor job of keeping Americans healthy and reducing the nation’s massive amount of healthcare spending, two CEOs of primary care companies said during a recent webinar. They argued that stakeholders in the primary care space need to come together to support more value-based care arrangements to reduce costs, advance population health and improve the patient experience.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
